Mark is an Associate Director in the health and life sciences team. Prior to joining Global Counsel, Mark worked in public affairs and policy at the Royal College of Surgeons of England, covering issues including the UK’s future relationship with the EU, patient safety and addressing the COVID-related backlog in elective care. Prior to this, he worked in healthcare consulting, with a particular focus on specialised commissioning and rare disease policy.
At GC, he works with corporates and investors from the health and life sciences sector to deliver strategic solutions to policy challenges.
Recent examples of his work include:
- Advising clients in the logistics sector on the rapidly evolving NHS procurement landscape
- Providing analysis to clients on the ramifications of new healthcare legislation, along with government strategy related to life sciences, health data and tech innovation
- Supporting life sciences and health IT companies in their work to navigate the political environment and develop government advocacy strategies.